MAP3K5 and myocardial infarction: Cardiac-specific ASK1 overexpression did not induce cardiac hypertrophy, however ASK1 transgenic mice displayed exacerbated dysfunction and increased infarct area size and cardiomyocyte apoptosis following myocardial infarction [98].